Onat, O. E. Et Al. 2006. MDM2 T309G polymorphism is associated with bladder cancer. ANTICANCER RESEARCH , vol.26 , 3473-3475.

Onat, O. E., Tez, M., Ozcelik, T., & Toruner, G. A., (2006). MDM2 T309G polymorphism is associated with bladder cancer. ANTICANCER RESEARCH , vol.26, 3473-3475.

Onat, ONUR Et Al. "MDM2 T309G polymorphism is associated with bladder cancer," ANTICANCER RESEARCH , vol.26, 3473-3475, 2006

Onat, ONUR E. Et Al. "MDM2 T309G polymorphism is associated with bladder cancer." ANTICANCER RESEARCH , vol.26, pp.3473-3475, 2006

Onat, O. E. Et Al. (2006) . "MDM2 T309G polymorphism is associated with bladder cancer." ANTICANCER RESEARCH , vol.26, pp.3473-3475.

@article{article, author={ONUR EMRE ONAT Et Al. }, title={MDM2 T309G polymorphism is associated with bladder cancer}, journal={ANTICANCER RESEARCH}, year=2006, pages={3473-3475} }